Borregaard ASA (BRGAY)
- Previous Close
35.50 - Open
35.50 - Bid --
- Ask --
- Day's Range
35.50 - 35.50 - 52 Week Range
28.00 - 38.09 - Volume
100 - Avg. Volume
100 - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.47
- PE Ratio (TTM)
23.20 - EPS (TTM)
1.53 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers for various applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry. The BioMaterials segment offers specialty cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. The Fine Chemicals segment provides fine chemical intermediates for contrast agents; and advanced bioethanol products. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
www.borregaard.com1,127
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: BRGAY
Performance Overview: BRGAY
Trailing total returns as of 4/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BRGAY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BRGAY
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
11.56%
Return on Assets (ttm)
9.06%
Return on Equity (ttm)
18.19%
Revenue (ttm)
7.26B
Net Income Avi to Common (ttm)
839M
Diluted EPS (ttm)
1.53
Balance Sheet and Cash Flow
Total Cash (mrq)
200M
Total Debt/Equity (mrq)
48.66%
Levered Free Cash Flow (ttm)
476.25M
Company Insights: BRGAY
BRGAY does not have Company Insights